Skip to main content

The Money Overview

The FTC says hospital price-transparency rules do not shield a company from deception claims

The Federal Trade Commission has told 24 of the nation’s largest health care services companies that following federal hospital price-transparency rules does not protect them from deception claims. The warning letters, announced October 5, concern routine, non-emergency care scheduled in advance. The agency set no penalty and no deadline, but it asked every recipient to review how it quotes prices.

What the FTC sent to 24 health care companies

The letters came from FTC Chairman Andrew N. Ferguson. They remind each recipient of its legal duty to give patients timely, accurate and complete pricing information for health care services. Failing to do so, the letters say, can be an unfair or deceptive practice under the law the FTC enforces.

The release is headlined as a warning to hospitals, but its text says health care services companies, and the page does not name the 24 recipients.

These are warning letters, not lawsuits. No fine is attached, no response date is stated, and the release does not mention a Commission vote. Ferguson urged recipients to review their price disclosure practices comprehensively and to take swift corrective action where needed.

Why meeting the CMS rules is not a shield

The letters call the price-transparency rules of the Centers for Medicare & Medicaid Services, or CMS, an important baseline. Complying with them, the letters say, does not mean a provider has met its obligations under Section 5 of the FTC Act. “The CMS rules do not create a safe harbor from FTC Act liability,” the release states.

The first of the two theories is deception. The letters say price is a material term, so clear and conspicuous disclosures are often needed. Leaving out a price may be deceptive if it would likely mislead reasonable consumers.

A disclosure can also deceive when it is incomplete. The letters give one example: a quote that omits physician or facility fees. A quote that covers only part of the expected course of care falls in the same category, and so does one that is inaccurate.

Retirement deadlines, in your inbox: Miss an enrollment or claim deadline and the money can be gone. The Retirement Money Brief keeps you ahead of the ones that matter, every weekday.

Get the Retirement Money Brief →

We may earn a commission from links on this page.

The second theory is unfairness. Under it, failing to provide transparent pricing may be unfair if it causes, or is likely to cause, substantial injury that consumers cannot reasonably avoid and that benefits to consumers or competition do not outweigh.

Incomplete, inaccurate or late price information can meet that test, the FTC says, when the provider could reasonably have had the figures in advance. Such information keeps patients from comparing providers before they book a procedure.

A contact-lens lawsuit shows the same price-versus-checkout theory

Three days before the hospital letters, the FTC and the states of Utah and Nevada announced a suit against Lens.com, its owner Cary Samourkachian and an affiliate, Speed Commerce LLC. The complaint, brought in federal court in Nevada, alleges that ads and the website show low contact-lens prices while a mandatory “Taxes & fees” charge at checkout often doubles them.

The FTC alleges that the charge sits below the visible part of the screen, so shoppers who click Continue never see it. It also alleges that the label implies state sales tax even though many states exempt contact lenses or have no sales tax. The agency says the fees cost consumers hundreds of millions of dollars.

“Lens.com advertised one price for contact lenses but charged a substantially higher price at checkout,” said Christopher Mufarrige, director of the FTC’s Bureau of Consumer Protection. The Commission voted 2-0 to authorize the complaint. Those are allegations, and no court has ruled.

The two actions are different. One is a lawsuit over a retailer’s checkout page, the other a set of warnings about how health care providers quote prices. Both turn on whether the price shown to a consumer is the full price.

Ferguson launched an FTC Healthcare Task Force on March 20, 2026. It draws staff from the Bureaus of Competition, Consumer Protection and Economics, plus the Office of Policy Planning and the Office of Technology. The FTC plans to add members from other agencies, including the Department of Health and Human Services and the Department of Justice.

What a patient can check when a quote and a bill differ

The letters create no new right for patients. The release announces no refund program or claims process, and it describes what the FTC expects of providers rather than what a billed patient can collect.

The FTC’s own examples still give a patient a short list to run against a quote for a scheduled procedure. Does the quote include the physician’s fees as well as the facility’s? Does it cover the whole expected course of care or only the first step? Was it given early enough to compare other providers?

A quote that leaves out a physician or facility fee is the specific shortfall the FTC named. A patient who holds a written estimate and a larger bill has the document that shows which pieces were missing.

With no recipient list, no deadline and no penalty, the next signal will be whether the FTC follows any of the 24 letters with a complaint. Until then, the open question for a patient is whether the price in hand covers everything the procedure will bill.

Was the bill higher than the quote?

A dispute over a hospital bill comes down to paperwork: what was quoted, what was billed and who decided what coverage would pay. A patient who cannot lay those three side by side is arguing from memory.

The Medicare Cost & Coverage Protection Kit includes the prior-authorization appeal steps for coverage denials, along with a medication and cost tracker. It also carries 51 state Medicare cost-help packs.

Get the appeal steps and cost tracker for a bill that missed the quote →


More Financial Reading

This article was produced with AI assistance and edited for accuracy against the sources linked above.

Avatar photo

Daniel Harper

Daniel is a finance writer covering personal finance topics including budgeting, credit, and beginner investing. He began his career contributing to his Substack, where he covered consumer finance trends and practical money topics for everyday readers. Since then, he has written for a range of personal finance blogs and fintech platforms, focusing on clear, straightforward content that helps readers make more informed financial decisions.​